 Jenna Guthmiller
Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthomyxoviridae | 6 | 2022 | 35 | 3.220 |
Why?
| | Antibodies, Viral | 14 | 2022 | 520 | 3.080 |
Why?
| | Influenza, Human | 10 | 2024 | 546 | 2.740 |
Why?
| | B-Lymphocytes | 10 | 2021 | 766 | 2.720 |
Why?
| | Influenza Vaccines | 13 | 2022 | 497 | 2.700 |
Why?
| | Immunity, Humoral | 13 | 2024 | 112 | 2.440 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 8 | 2022 | 20 | 1.820 |
Why?
| | Malaria | 8 | 2021 | 48 | 1.770 |
Why?
| | Orthomyxoviridae Infections | 4 | 2022 | 54 | 1.740 |
Why?
| | Influenza A Virus, H1N1 Subtype | 4 | 2024 | 139 | 1.680 |
Why?
| | Epitopes | 7 | 2023 | 435 | 1.400 |
Why?
| | Antibody Formation | 6 | 2024 | 266 | 1.310 |
Why?
| | Antibodies, Neutralizing | 7 | 2021 | 222 | 1.280 |
Why?
| | Germinal Center | 3 | 2020 | 48 | 1.260 |
Why?
| | Immunologic Memory | 6 | 2021 | 313 | 1.180 |
Why?
| | Antigens, Viral | 5 | 2022 | 176 | 1.130 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2021 | 92 | 0.900 |
Why?
| | Antibodies, Monoclonal | 6 | 2023 | 1262 | 0.840 |
Why?
| | Antigens | 1 | 2023 | 318 | 0.770 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 295 | 0.760 |
Why?
| | Interleukin-10 | 3 | 2021 | 299 | 0.760 |
Why?
| | Amino Sugars | 1 | 2021 | 8 | 0.760 |
Why?
| | Eggs | 1 | 2021 | 30 | 0.740 |
Why?
| | Polysaccharides | 1 | 2021 | 78 | 0.730 |
Why?
| | Influenza A virus | 1 | 2021 | 90 | 0.720 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2023 | 615 | 0.690 |
Why?
| | Coronavirus | 1 | 2020 | 40 | 0.690 |
Why?
| | Plasma Cells | 4 | 2021 | 56 | 0.660 |
Why?
| | Antibodies, Protozoan | 3 | 2021 | 30 | 0.640 |
Why?
| | Vaccination | 5 | 2024 | 1204 | 0.610 |
Why?
| | Protein Engineering | 1 | 2019 | 98 | 0.590 |
Why?
| | Malaria Vaccines | 1 | 2015 | 6 | 0.490 |
Why?
| | Molecular Biology | 1 | 2015 | 56 | 0.470 |
Why?
| | Cross Reactions | 4 | 2021 | 117 | 0.450 |
Why?
| | Lymphocyte Activation | 4 | 2021 | 1037 | 0.410 |
Why?
| | Antibody Affinity | 3 | 2021 | 52 | 0.400 |
Why?
| | Plasmodium | 3 | 2017 | 9 | 0.390 |
Why?
| | Plasmodium yoelii | 3 | 2021 | 4 | 0.370 |
Why?
| | Epitopes, B-Lymphocyte | 2 | 2021 | 16 | 0.370 |
Why?
| | Hemagglutinins | 2 | 2021 | 9 | 0.360 |
Why?
| | Animals | 17 | 2022 | 31708 | 0.330 |
Why?
| | Plasmodium falciparum | 2 | 2020 | 27 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2021 | 959 | 0.300 |
Why?
| | Humans | 25 | 2024 | 114698 | 0.280 |
Why?
| | Antimalarials | 3 | 2021 | 24 | 0.270 |
Why?
| | Mice | 11 | 2022 | 14871 | 0.260 |
Why?
| | Receptors, Antigen, B-Cell | 2 | 2023 | 107 | 0.240 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2023 | 69 | 0.210 |
Why?
| | Immunoglobulin A | 2 | 2021 | 166 | 0.200 |
Why?
| | Immune System | 1 | 2023 | 172 | 0.200 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 4694 | 0.190 |
Why?
| | DNA, Protozoan | 2 | 2020 | 26 | 0.190 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2018 | 687 | 0.190 |
Why?
| | Cell Differentiation | 2 | 2021 | 1701 | 0.190 |
Why?
| | Immunodominant Epitopes | 1 | 2021 | 25 | 0.190 |
Why?
| | Disease Resistance | 1 | 2021 | 27 | 0.190 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 40 | 0.180 |
Why?
| | Chickens | 1 | 2021 | 177 | 0.180 |
Why?
| | Phosphatidylserines | 1 | 2021 | 87 | 0.180 |
Why?
| | Genes, Immunoglobulin | 1 | 2020 | 26 | 0.180 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 35 | 0.180 |
Why?
| | Complementarity Determining Regions | 1 | 2020 | 43 | 0.180 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 17 | 0.180 |
Why?
| | Antibody Specificity | 1 | 2020 | 176 | 0.180 |
Why?
| | Hemolysis | 1 | 2021 | 146 | 0.170 |
Why?
| | Symptom Assessment | 1 | 2020 | 119 | 0.170 |
Why?
| | Protein Domains | 1 | 2020 | 207 | 0.160 |
Why?
| | Receptors, OX40 | 2 | 2017 | 15 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 591 | 0.160 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2021 | 127 | 0.160 |
Why?
| | Immunoglobulin Light Chains | 1 | 2019 | 35 | 0.160 |
Why?
| | Phosphoproteins | 1 | 2021 | 298 | 0.160 |
Why?
| | Immunity | 1 | 2019 | 121 | 0.160 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2019 | 72 | 0.160 |
Why?
| | Vaccines, Attenuated | 2 | 2019 | 112 | 0.160 |
Why?
| | Immunity, Heterologous | 1 | 2018 | 2 | 0.150 |
Why?
| | Antigenic Variation | 1 | 2018 | 9 | 0.150 |
Why?
| | Seasons | 1 | 2020 | 442 | 0.150 |
Why?
| | Adjuvants, Immunologic | 1 | 2019 | 206 | 0.150 |
Why?
| | Immunophenotyping | 1 | 2019 | 274 | 0.150 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2017 | 11 | 0.150 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 797 | 0.150 |
Why?
| | Malaria, Falciparum | 1 | 2017 | 25 | 0.150 |
Why?
| | Autoimmunity | 1 | 2023 | 813 | 0.150 |
Why?
| | Erythrocytes | 3 | 2021 | 591 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2017 | 68 | 0.140 |
Why?
| | Th1 Cells | 1 | 2017 | 123 | 0.140 |
Why?
| | Software | 1 | 2020 | 530 | 0.140 |
Why?
| | Flow Cytometry | 2 | 2016 | 1083 | 0.130 |
Why?
| | Male | 11 | 2022 | 55606 | 0.130 |
Why?
| | Female | 12 | 2022 | 59520 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 993 | 0.130 |
Why?
| | Interferon Type I | 1 | 2016 | 128 | 0.130 |
Why?
| | Cell Line | 1 | 2021 | 2637 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2016 | 383 | 0.110 |
Why?
| | Adult | 8 | 2021 | 30553 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2017 | 2570 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 339 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3535 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2021 | 1737 | 0.110 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2015 | 194 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 501 | 0.110 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1313 | 0.100 |
Why?
| | Neutralization Tests | 2 | 2021 | 63 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1481 | 0.090 |
Why?
| | Middle Aged | 4 | 2021 | 26738 | 0.080 |
Why?
| | Healthy Volunteers | 2 | 2019 | 197 | 0.080 |
Why?
| | Biomarkers | 1 | 2019 | 3408 | 0.080 |
Why?
| | Computational Biology | 2 | 2021 | 530 | 0.070 |
Why?
| | Immunoglobulin G | 2 | 2020 | 770 | 0.060 |
Why?
| | Neuraminidase | 1 | 2022 | 22 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 3886 | 0.050 |
Why?
| | Convalescence | 1 | 2021 | 15 | 0.050 |
Why?
| | Binding Sites, Antibody | 1 | 2021 | 36 | 0.050 |
Why?
| | Epitope Mapping | 1 | 2021 | 51 | 0.050 |
Why?
| | Chick Embryo | 1 | 2021 | 122 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2020 | 73 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 47 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 143 | 0.040 |
Why?
| | Plasma | 1 | 2021 | 211 | 0.040 |
Why?
| | Immunogenicity, Vaccine | 1 | 2019 | 25 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 188 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2019 | 68 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2020 | 94 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 439 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2018 | 20 | 0.040 |
Why?
| | Galectins | 1 | 2018 | 22 | 0.040 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2018 | 22 | 0.040 |
Why?
| | Glycosylation | 1 | 2018 | 130 | 0.040 |
Why?
| | Receptors, Interferon | 1 | 2017 | 47 | 0.040 |
Why?
| | T-Box Domain Proteins | 1 | 2017 | 92 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 1982 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 448 | 0.030 |
Why?
| | Protein Binding | 1 | 2021 | 1890 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 725 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1176 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 1950 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 10471 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1518 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1320 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 1841 | 0.030 |
Why?
| | Adolescent | 2 | 2020 | 17853 | 0.020 |
Why?
| | Autoantibodies | 1 | 2017 | 1346 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2320 | 0.020 |
Why?
| | Signal Transduction | 1 | 2018 | 4515 | 0.020 |
Why?
| | United States | 1 | 2020 | 12186 | 0.010 |
Why?
| | Aged | 1 | 2020 | 19074 | 0.010 |
Why?
|
|
Guthmiller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|